Skip to main content
. 2021 Dec 10;106(1):25–56. doi: 10.1007/s00253-021-11713-0

Fig. 4.

Fig. 4

Joint distribution of novel technologies used for new vaccines against infection diseases in humans under clinical trials applied to the European Medicines Agency (EMA) or the Food and Drug Administration (FDA)